Sun Pharma Advanced Research Company Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Sun Pharma Advanced Research Company Profile :

Sun Pharma Advanced Research Company Limited is an Indian company engaged in the business of Pharmaceuticals Research & Development.

Company develops anti-cancer formulation, Biodegradable Implants, Dry powder Inhalation, as well as Anti-inflammatory drugs.


Sun Pharma Advanced Research Company ResultsBSE Code : 532872
NSE Symbol : SPARC
ISIN No. : INE232I01014
Industry : Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Sun Pharma Advanced Research Company or you are an stock market analyst then i am sure you might for Quarterly Results of Sun Pharma Advanced Research Company.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Sun Pharma Advanced Research Company. That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of Sun Pharma Advanced Research Company.

Sun Pharma Advanced Research Company Q1 Results 2017-18 :

Sun Pharma Advanced Research Company will announce its Q1 FY 2017-18 Results in August 2017. Will soon update the below mentioned table.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Sun Pharma Advanced Research Company will announce its Q2 FY 2017-18 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Sun Pharma Advanced Research Company will announce its Q3 FY 2017-18 Results in the month of January 2018.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Sun Pharma Advanced Research Company will announce its Q4 FY 2017-18 Results in the month of April 2018.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Sun Pharma Advanced Research Company will announce its FY 2017-18 Results in the month of April 2018.

(Values in Cr.) FY 2017-18 Standalone FY 2017-18 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Sun Pharma Advanced Research Company Previous Year’s Results (FY 2016-17) :

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : If you like this information about Sun Pharma Advanced Research Company Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.